journal article·2023-02-09Open access

Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications

Yamei Xu, Qiyuan Hu, Zongyun Wei, Yi Ou, Youde Cao, Hang Zhou, Mengna Wang, Kexiao Yu, Bing Liang

Biomaterials Research· Volume 27· Issue 1

Abstract

Diabetic ulcers (DUs) are one of the most serious complications of diabetes mellitus. The application of a functional dressing is a crucial step in DU treatment and is associated with the patient's recovery and prognosis. However, traditional dressings with a simple structure and a single function cannot meet clinical requirements. Therefore, researchers have turned their attention to advanced polymer dressings and hydrogels to solve the therapeutic bottleneck of DU treatment. Hydrogels are a class of gels with a three-dimensional network structure that have good moisturizing properties and permeability and promote autolytic debridement and material exchange. Moreover, hydrogels mimic the natural environment of the extracellular matrix, providing suitable surroundings for cell proliferation. Thus, hydrogels with different mechanical strengths and biological properties have been extensively explored as DU dressing platforms. In this review, we define different types of hydrogels and elaborate the mechanisms by which they repair DUs. Moreover, we summarize the pathological process of DUs and review various additives used for their treatment. Finally, we examine the limitations and obstacles that exist in the development of the clinically relevant applications of these appealing technologies. This review defines different types of hydrogels and carefully elaborate the mechanisms by which they repair diabetic ulcers (DUs), summarizes the pathological process of DUs, and reviews various bioactivators used for their treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Diabetic Foot Ulcer Assessment and Management · Pressure Ulcer Prevention and Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pathology, College of Basic Medicine, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong Distinct, Chongqing 400016, P.R. China.

Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong Distinct, Chongqing 400016, P.R. China.

Department of Pathology, the First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong Distinct, Chongqing 400042, P.R. China.

Department of Orthopedics, Chongqing Traditional Chinese Medicine Hospital, No. 6 Panxi Seventh Branch Road, Jiangbei District, Chongqing 400021, P.R. China.

Institute of Ultrasound Imaging of Chongqing Medical University, 1 Yixueyuan Road, Yuzhong Distinct, Chongqing 400016, P.R. China.

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · Chongqing Special Postdoctoral Science Foundation · Natural Science Foundation of Chongqing

References (100+)

Show source-provided references
1. Country and Regional Data Group. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.
2. 10.1038/nrendo.2016.7410.1038/nrendo.2016.74 ↗
3. 10.2337/dc17-196210.2337/dc17-1962 ↗
4. 10.1016/j.actbio.2021.10.04510.1016/j.actbio.2021.10.045 ↗
5. 10.1038/nrendo.2015.13010.1038/nrendo.2015.130 ↗
6. 10.1161/01.CIR.96.1.2510.1161/01.CIR.96.1.25 ↗
7. 10.1016/j.cmet.2021.07.00110.1016/j.cmet.2021.07.001 ↗
8. 10.1038/s41572-019-0092-110.1038/s41572-019-0092-1 ↗
9. 10.1016/j.addr.2019.03.00610.1016/j.addr.2019.03.006 ↗
10. 10.1016/j.trsl.2021.05.00610.1016/j.trsl.2021.05.006 ↗
11. 10.1093/burnst/tkac05110.1093/burnst/tkac051 ↗
12. 10.1016/j.phrs.2022.10632610.1016/j.phrs.2022.106326 ↗
13. 10.1016/j.chom.2019.04.00610.1016/j.chom.2019.04.006 ↗
14. 10.1016/j.chom.2019.03.00610.1016/j.chom.2019.03.006 ↗
15. 10.1016/S0140-6736(21)00724-810.1016/S0140-6736(21)00724-8 ↗
16. 10.2337/dci22-004310.2337/dci22-0043 ↗
17. American Diabetes Association (ADA). 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S135–51.10.2337/dc20-S011 ↗
18. 10.1146/annurev-bioeng-060418-05242210.1146/annurev-bioeng-060418-052422 ↗
19. 10.1038/200378a010.1038/200378a0 ↗
20. Del RJ. Wound care in the dermatology office: where are we in 2011? J Am Acad Dermatol. 2011;64(3 Suppl):S1–07.10.1016/j.jaad.2010.10.038 ↗
21. 10.1007/s13346-021-00941-610.1007/s13346-021-00941-6 ↗
22. 10.1016/j.ijbiomac.2020.12.20210.1016/j.ijbiomac.2020.12.202 ↗
23. 10.1016/j.ijbiomac.2022.03.00210.1016/j.ijbiomac.2022.03.002 ↗
24. 10.1016/j.bioactmat.2022.11.01910.1016/j.bioactmat.2022.11.019 ↗
25. 10.2147/IJN.S27600110.2147/IJN.S276001 ↗
26. 10.1063/5.004668210.1063/5.0046682 ↗
27. 10.1001/jama.287.19.257010.1001/jama.287.19.2570 ↗
28. 10.1097/01.ASN.0000077408.15865.0610.1097/01.ASN.0000077408.15865.06 ↗
29. 10.1161/CIRCRESAHA.109.21344710.1161/CIRCRESAHA.109.213447 ↗
30. 10.1146/annurev.nu.16.070196.00131510.1146/annurev.nu.16.070196.001315 ↗
31. 10.1161/CIRCRESAHA.110.22354510.1161/CIRCRESAHA.110.223545 ↗
32. 10.1056/NEJM19730419288160910.1056/NEJM197304192881609 ↗
33. Akagi Y, et al. Immunohistochemical localization for aldose reductase in diabetic lenses. Invest Ophthalmol Vis Sci. 1987;28(1):163–167. 1:CAS:528:DyaL2sXkt1Wnuro%3D
34. 10.1074/jbc.M60041820010.1074/jbc.M600418200 ↗
35. 10.2337/diabetes.47.6.96110.2337/diabetes.47.6.961 ↗
36. 10.1038/s41392-020-00311-710.1038/s41392-020-00311-7 ↗
37. 10.1172/JCI2481910.1172/JCI24819 ↗
38. 10.5551/jat.RV1701410.5551/jat.RV17014 ↗
39. 10.2337/diab.32.11.98810.2337/diab.32.11.988 ↗
40. 10.2337/diab.28.6.60410.2337/diab.28.6.604 ↗
41. 10.3389/fendo.2022.97305810.3389/fendo.2022.973058 ↗
42. 10.1016/j.tips.2006.04.00310.1016/j.tips.2006.04.003 ↗
43. 10.1038/414813a10.1038/414813a ↗
44. 10.3390/ijms2314793010.3390/ijms23147930 ↗
45. 10.1016/j.bcp.2022.11525610.1016/j.bcp.2022.115256 ↗
46. 10.1161/CIRCULATIONAHA.112.12751410.1161/CIRCULATIONAHA.112.127514 ↗
47. 10.1186/1475-2840-13-10510.1186/1475-2840-13-105 ↗
48. 10.1016/j.mvr.2010.01.00310.1016/j.mvr.2010.01.003 ↗
49. 10.3389/fphar.2021.71633210.3389/fphar.2021.716332 ↗
50. 10.1186/s10020-022-00544-y10.1186/s10020-022-00544-y ↗
51. 10.1186/s12929-022-00851-w10.1186/s12929-022-00851-w ↗
52. 10.1038/nrm.2017.2210.1038/nrm.2017.22 ↗
53. Chen Y, et al. Transcriptional programming in arteriosclerotic disease: a multifaceted function of the Runx2 (Runt-Related Transcription Factor 2). Arterioscler Thromb Vasc Biol. 2021;41(1):20–34. 1:CAS:528:DC%2BB3MXhtFWgt7s%3D10.1161/ATVBAHA.120.313791 ↗
54. 10.1161/CIRCRESAHA.114.30296810.1161/CIRCRESAHA.114.302968 ↗
55. Li Y, et al. O-GlcNAcylation in immunity and inflammation: An intricate system (Review). Int J Mol Med. 2019;44(2):363–374. 1:CAS:528:DC%2BC1MXitVOisrzM
56. 10.1073/pnas.080619810510.1073/pnas.0806198105 ↗
57. 10.1042/BST035085310.1042/BST0350853 ↗
58. 10.1093/ndt/11.supp5.1710.1093/ndt/11.supp5.17 ↗
59. 10.1023/A:101606891726610.1023/A:1016068917266 ↗
60. 10.3892/ijmm.2017.309810.3892/ijmm.2017.3098 ↗
61. 10.1111/acel.1354310.1111/acel.13543 ↗
62. 10.1016/j.ijbiomac.2021.07.05810.1016/j.ijbiomac.2021.07.058 ↗
63. 10.1016/j.cyto.2020.15499110.1016/j.cyto.2020.154991 ↗
64. 10.3390/ijms2212653010.3390/ijms22126530 ↗
65. 10.1007/s00018-015-2091-z10.1007/s00018-015-2091-z ↗
66. 10.1155/2015/73245010.1155/2015/732450 ↗
67. 10.1016/j.diabres.2011.12.00610.1016/j.diabres.2011.12.006 ↗
68. 10.1007/s11427-014-4710-610.1007/s11427-014-4710-6 ↗
69. Azhar A et al. Prevalence of peripheral arterial disease in diabetic foot ulcer patients and its impact in limb salvage. Int J Low Extrem Wounds. 2021:0(0):2133276791.
70. 10.1053/j.semvascsurg.2019.02.00110.1053/j.semvascsurg.2019.02.001 ↗
71. 10.4239/wjd.v12.i6.82710.4239/wjd.v12.i6.827 ↗
72. 10.3390/ijms2105183510.3390/ijms21051835 ↗
73. 10.2337/dc12-196410.2337/dc12-1964 ↗
74. 10.3390/ijms2203103110.3390/ijms22031031 ↗
75. 10.1007/s12264-022-00878-x10.1007/s12264-022-00878-x ↗
76. 10.1016/S1474-4422(22)00188-010.1016/S1474-4422(22)00188-0 ↗
77. 10.1098/rsob.20022310.1098/rsob.200223 ↗
78. 10.1177/153473461247430310.1177/1534734612474303 ↗
79. 10.7554/eLife.7207110.7554/eLife.72071 ↗
80. 10.1371/journal.pone.003236610.1371/journal.pone.0032366 ↗
81. 10.1038/nm.388710.1038/nm.3887 ↗
82. 10.1016/j.jdiacomp.2018.01.01510.1016/j.jdiacomp.2018.01.015 ↗
83. 10.1371/journal.pone.022057710.1371/journal.pone.0220577 ↗
84. 10.1016/j.yexcr.2021.11255010.1016/j.yexcr.2021.112550 ↗
85. 10.2337/db17-123810.2337/db17-1238 ↗
86. 10.1016/j.redox.2015.01.00210.1016/j.redox.2015.01.002 ↗
87. 10.1038/s41598-019-55644-310.1038/s41598-019-55644-3 ↗
88. 10.1016/S0891-5849(00)00514-110.1016/S0891-5849(00)00514-1 ↗
89. 10.1371/journal.pone.020185510.1371/journal.pone.0201855 ↗
90. 10.1007/s11357-014-9623-610.1007/s11357-014-9623-6 ↗
91. 10.1016/S0891-5849(96)00501-110.1016/S0891-5849(96)00501-1 ↗
92. 10.2337/db12-171410.2337/db12-1714 ↗
93. Pitocco D, et al. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26–37. 1:STN:280:DC%2BB3M%2FkslamsA%3D%3D
94. 10.3389/fendo.2022.88165910.3389/fendo.2022.881659 ↗
95. 10.1136/bmj.b77310.1136/bmj.b773 ↗
96. 10.1111/iwj.1276010.1111/iwj.12760 ↗
97. 10.1111/iwj.1395610.1111/iwj.13956 ↗
98. 10.2337/dc15-200110.2337/dc15-2001 ↗
99. Dumville JC, et al. Hydrogel dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev. 2013;2013(7):D9101.
100. 10.1038/193293a010.1038/193293a0 ↗